The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: UK-based biopharma company, Xenetic Biosciences, said in a statement that the recruitment process for the tri...
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...
Pharmaceutical and biotechnology companies reap the most benefit from their strategic collaborations, by working with su...
Recruitment and retention of research participants is often the most labor-intensive and difficult component of clinical...
Any regulatory body's primary concern is to provide safe and efficacious medicine at an acceptable healthcare cost to ...
Singapore: Quintiles appointed Ms Jenny Zhang as VP and general manager of Asian laboratories. She will be responsible f...
Singapore: The training of next-generation clinical investigators in China is at the core of a new collaboration between...
The loss of patents on the last generation of blockbuster products has forced multinational pharmaceutical companies t...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore:Â Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted ...
Hyderabad:Â GVK Biosciences entered into a collaboration agreement with US-based Endo Pharmaceuticals to discover nove...
Singapore: pSivida, a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye di...
Singapore: Australia-based contract research organization, Novotech, recently announced that it has expanded its Hong Ko...
Singapore: Biostar Pharmaceuticals, a PRC-based manufacturer and marketer of pharmaceutical and health supplement produc...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore:Â Parexel International's, chairman and CEO, Mr Josef von Rickenbach, has been named the 2013 chairman of th...
Singapore: Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leadin...
Singapore: WuXi PharmaTech, a leading pharmaceutical, biotechnology and medical device R&D services company with ope...
Singapore: Pharmaceutical Product Development (PPD) has appointed Dr Andrew Cunningham as vice president of central labo...
Singapore: Australian-based CRO, CPR Pharma Services, is launching a service aimed at US-based companies who want access...
Singapore: The toxicology facility of WuXi PharmaTech at Suzhou, China, has received a certificate of Good Laboratory Pr...
Big news in 2013 will be the growth of biosimilars in the biologics segment. By the end of the year, biosimilars will ac...
Singapore: Japan is considering new legislation to regulate clinical studies in the country, according to a report publi...
The bioservices sector witnessed a growth of 15.5 percent in 2011-12 in spite of facing many issues from the regulatory ...
